Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.

Abbosh, C; Swanton, C; Birkbak, N J

Abbosh, C; Swanton, C; Birkbak, N J.

Afiliación

Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK; Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK.
Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK; Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. Electronic address: nicolai.birkbak@crick.ac.uk.

Ann Oncol ; 29(3): 535-537, 2018 03 01.

Article en En | MEDLINE | ID: mdl-29351578

Asunto(s)

Neoplasias de la Mama; ADN Tumoral Circulante; Resistencia a Antineoplásicos; Humanos; Mutación; Inhibidores de Proteínas Quinasas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google